Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients. Commentary

• Published in: Clinical infectious diseases Vol. 43; no. 3; pp. 365 - 376
• Main Authors: MCGOVERN, Barbara H, DITELBERG, Jeremy S, SAX, Paul E, GRAEME-COOK, Fiona, HIBBERD, Patricia L, ZEREMSKI, Marija, TALAL, Andrew H, TAYLOR, Lynn E, GANDHI, Rajesh T, CHRISTOPOULOS, Katerina A, CHAPMAN, Stacey, SCHWARTZAPFEL, Beth, RINDLER, Emily, FIORINO, Anne-Marie, TAUHEED ZAMAN, M
• Format: Journal Article
• Language: English
• Published: Chicago, IL University of Chicago Press 2006
• Subjects: Biological and medical sciences; Gastroenterology. Liver. Pancreas. Abdomen; Human viral diseases; Infectious diseases; Liver. Biliary tract. Portal circulation. Exocrine pancreas; Medical sciences; Other diseases. Semiology; Viral diseases; Viral diseases of the lymphoid tissue and the blood. Aids; Viral hepatitis; Hepatic fibrosis; Immunopathology; Seropositivity; Typing; Hepatic disease; Genotype; AIDS; Immune deficiency; Infection; Microbiological investigation; Fatty liver; Viral disease; Digestive diseases; Nucleoside analog; Viral hepatitis C
• ISSN: 1058-4838; 1537-6591